BRIEF published on 10/23/2024 at 08:05, 29 days 5 hours ago Lloyds Banking Group Reports Robust Q3 2024 Financial Performance Financial Performance Asset Quality Income Growth Lloyds Banking Group Q3 2024
PRESS RELEASE published on 10/23/2024 at 08:00, 29 days 5 hours ago 2024 Q3 Interim Management Statement Lloyds Banking Group plc reports robust financial performance in Q3 2024, reaffirms guidance for 2024, with net income down 7% and operating costs up 5% Financial Performance Net Income Lloyds Banking Group Guidance Q3 2024
BRIEF published on 07/25/2024 at 10:20, 3 months 27 days ago Lloyds Banking Group Reports 2024 Half-Year Results Financial Performance Dividend Lloyds Banking Group Strategic Targets 2024 Results
PRESS RELEASE published on 07/25/2024 at 10:15, 3 months 27 days ago 2024 Half-Year Results Lloyds Banking Group PLC reports robust 2024 Half-Year Results with solid income performance, cost discipline, and strong capital generation, reaffirming 2024 and 2026 strategic objectives Financial Performance Capital Generation Lloyds Banking Group Strategic Objectives 2024 Half-year Results
BRIEF published on 04/24/2024 at 08:05, 6 months 27 days ago Lloyds Banking Group Reports Q1 2024 Financial Results Lloyds Banking Group CET1 Ratio Q1 2024 Financial Results Banking Net Interest Margin Profit Analysis
PRESS RELEASE published on 04/24/2024 at 08:00, 6 months 27 days ago 2024 Q1 Interim Management Statement Lloyds Banking Group plc releases Q1 2024 Interim Management Statement, reporting solid net income, cost discipline, and strong asset quality. Financial performance in line with expectations Financial Performance Asset Quality Lloyds Banking Group PLC Q1 2024 Interim Management Statement
PRESS RELEASE published on 02/22/2024 at 18:05, 8 months 27 days ago 2023 Form 20F Filed Lloyds Banking Group files Annual Report on Form 20-F for year ended 31 December 2023 with the SEC. Shareholders can request hard copies Shareholders Securities And Exchange Commission Annual Report Lloyds Banking Group Form 20-F
BRIEF published on 02/22/2024 at 18:05, 8 months 27 days ago Lloyds Banking Group Announces Filing of Its Form 20-F Annual Report Annual Report Finance SEC Lloyds Banking Group Form 20-F
PRESS RELEASE published on 02/22/2024 at 08:55, 8 months 28 days ago 2023 Full Year Results Lloyds Banking Group PLC reports strong 2023 full-year results, meeting guidance. Proven financial performance, strategic progress, and sustainable future commitments highlighted Financial Performance Sustainable Future 2023 Full Year Results Lloyds Banking Group PLC Strategic Progress
BRIEF published on 02/22/2024 at 08:55, 8 months 28 days ago Lloyds Banking Group Annual Results 2023 Dividends Annual Results 2023 Lloyds Banking Group Strategy And Growth Sustainable Finance
Published on 11/21/2024 at 13:30, 13 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 13 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 43 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 43 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 43 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 8 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 28 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 45 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 23 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
